H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation

H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation

Background/Aims: Apoptosis, fibrosis and NLRP3 inflammasome activation are involved in the development of diabetic cardiomyopathy (DCM). Human recombinant relaxin-3 (H3 relaxin) is a novel bioactive peptide that inhibits cardiac injury; however, whether H3 relaxin prevents cardiac injury in rats wit...

Full description

Bibliographic Details
Main Authors: Xiaohui Zhang, Liya Pan, Kelaier Yang, Yu Fu, Yue Liu, Jinyu Chi, Xin Zhang, Siting Hong, Xiao Ma, Xinhua Yin
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-10-01
Series:Cellular Physiology and Biochemistry
Subjects:
H3 relaxin
Diabetic cardiomyopathy
NLRP3 inflammasome
Apoptosis
Cardiac fibrosis
Online Access:https://www.karger.com/Article/FullText/481843

Internet

https://www.karger.com/Article/FullText/481843

Similar Items